1. Home
  2. SHC vs TGTX Comparison

SHC vs TGTX Comparison

Compare SHC & TGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sotera Health Company

SHC

Sotera Health Company

HOLD

Current Price

$17.14

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

HOLD

Current Price

$30.95

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHC
TGTX
Founded
2015
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
5.5B
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
SHC
TGTX
Price
$17.14
$30.95
Analyst Decision
Buy
Strong Buy
Analyst Count
6
4
Target Price
$17.80
$54.75
AVG Volume (30 Days)
2.5M
1.6M
Earning Date
11-04-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.20
2.78
Revenue
$1,150,379,000.00
$531,898,000.00
Revenue This Year
$6.41
$87.88
Revenue Next Year
$5.89
$48.75
P/E Ratio
$87.90
$11.16
Revenue Growth
2.67
100.88
52 Week Low
$9.53
$25.28
52 Week High
$17.78
$46.48

Technical Indicators

Market Signals
Indicator
SHC
TGTX
Relative Strength Index (RSI) 59.59 46.68
Support Level $16.55 $30.40
Resistance Level $17.00 $32.30
Average True Range (ATR) 0.34 1.13
MACD 0.00 -0.00
Stochastic Oscillator 73.44 51.75

Price Performance

Historical Comparison
SHC
TGTX

About SHC Sotera Health Company

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). In addition, it is developing TG-1701 (BTK inhibitor), Azer-Cel (allogeneic CD19 CAR T), and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders, which are under Phase 1 trials. Geographically, the company generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from sales in other countries.

Share on Social Networks: